Literature DB >> 23440300

Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides.

Floyd A Beckford1, Jeffrey Thessing, Alyssa Stott, Alvin A Holder, Oleg G Poluektov, Liya Li, Navindra P Seeram.   

Abstract

A series of copper complexes were synthesized from benzo[d][1,3]dioxole-5-carbaldehyde (piperonal) thio-semicarbazones (RHpTSC where R=H, CH3, C2H5 or C6H5 (Ph)). The complexes show interesting variations in geometry depending on the thiosemicarbazone; a dinuclear complex [Cu(HpTSC)Cl]2, a mononuclear complex [Cu(RHpTSC)2Cl2] (R=CH3 or C2H5) and another mononuclear complex [Cu(PhHpTSC)(PhpTSC)Cl] was generated. The complexes bind in a moderately strong fashion to DNA with binding constants on the order of 10(4)M(‒1). They are also strong binders of human serum albumin with binding constants near 10(4) M(‒1). The complexes show good in vitro cytotoxic profiles against two human colon cancer cell lines (HCT-116 and HT29) and two human breast cancer cell lines (MCF-7 and MDA-MB-231) with IC50 values in the low millimolar concentration range.

Entities:  

Keywords:  Anticancer; DNA binding; Human serum albumin; Structural variation; Thiosemicarbazones

Year:  2012        PMID: 23440300      PMCID: PMC3579949          DOI: 10.1016/j.inoche.2011.10.032

Source DB:  PubMed          Journal:  Inorg Chem Commun        ISSN: 1387-7003            Impact factor:   2.495


  11 in total

Review 1.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Authors:  Ulrich Kragh-Hansen; Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

2.  Influence of surface shape on DNA binding of bimetallo helicates.

Authors:  Jemma C Peberdy; Jaroslav Malina; Syma Khalid; Michael J Hannon; Alison Rodger
Journal:  J Inorg Biochem       Date:  2007-07-16       Impact factor: 4.155

3.  Synthesis and characterization of novel palladium(II) complexes of bis(thiosemicarbazone). Structure, cytotoxic activity and DNA binding of Pd(II)-benzyl bis(thiosemicarbazonate).

Authors:  A I Matesanz; J M Pérez; P Navarro; J M Moreno; E Colacio; P Souza
Journal:  J Inorg Biochem       Date:  1999-07-30       Impact factor: 4.155

4.  Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.

Authors:  Floyd Beckford; Deidra Dourth; Michael Shaloski; Jacob Didion; Jeffrey Thessing; Jason Woods; Vernon Crowell; Nikolay Gerasimchuk; Antonio Gonzalez-Sarrías; Navindra P Seeram
Journal:  J Inorg Biochem       Date:  2011-08       Impact factor: 4.155

5.  The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells.

Authors:  I H Hall; K G Rajendran; D X West; A E Liberta
Journal:  Anticancer Drugs       Date:  1993-04       Impact factor: 2.248

6.  Synthesis and characterization of mixed-ligand diimine-piperonal thiosemicarbazone complexes of ruthenium(II): Biophysical investigations and biological evaluation as anticancer and antibacterial agents.

Authors:  Floyd A Beckford; Jeffrey Thessing; Michael Shaloski; P Canisius Mbarushimana; Alyssa Brock; Jacob Didion; Jason Woods; Antonio Gonzalez-Sarrías; Navindra P Seeram
Journal:  J Mol Struct       Date:  2011-04-19       Impact factor: 3.196

7.  Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.

Authors:  Ana I Matesanz; Pilar Souza
Journal:  J Inorg Biochem       Date:  2006-10-05       Impact factor: 4.155

8.  Novel, quinone-thiosemicarbazone hybrid (QTSCHY) non-platinum antitumor agents: inhibition of DNA biosynthesis in P388 lymphocytic cells by coordinatively unsaturated copper(II) and iron(III) complexes of naphthoquinone thiosemicarbazones.

Authors:  S Padhye; R Chikate; A Kumbhar; J M Shallom; M P Chitnis
Journal:  Biometals       Date:  1992       Impact factor: 2.949

9.  Studies on the interaction of copper complexes of (-)-epicatechin gallate and (-)-epigallocatechin gallate with calf thymus DNA.

Authors:  Kalyan Sundar Ghosh; Bijaya Ketan Sahoo; Deblina Jana; Swagata Dasgupta
Journal:  J Inorg Biochem       Date:  2008-05-06       Impact factor: 4.155

10.  Transition metal complexes of phenanthrenequinone thiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in vitro anticancer activity against human breast cancer cell-line, T47D.

Authors:  Zahra Afrasiabi; Ekk Sinn; Shreelekha Padhye; Sabari Dutta; Subhash Padhye; Chris Newton; Christopher E Anson; Annie K Powell
Journal:  J Inorg Biochem       Date:  2003-07-01       Impact factor: 4.155

View more
  3 in total

1.  A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα.

Authors:  Shayna Sandhaus; Rosella Taylor; Tiffany Edwards; Alexis Huddleston; Ykeysha Wooten; Ramaiyer Venkatraman; Ralph T Weber; Antonio González-Sarrías; Patrick M Martin; Patrice Cagle; Yuk-Ching Tse-Dinh; Stephen J Beebe; Navindra Seeram; Alvin A Holder
Journal:  Inorg Chem Commun       Date:  2016-02       Impact factor: 2.495

2.  Binuclear and tetranuclear Zn(ii) complexes with thiosemicarbazones: synthesis, X-ray crystal structures, ATP-sensing, DNA-binding, phosphatase activity and theoretical calculations.

Authors:  Piyali Adak; Bipinbihari Ghosh; Antonio Bauzá; Antonio Frontera; Steven R Herron; Shyamal Kumar Chattopadhyay
Journal:  RSC Adv       Date:  2020-03-30       Impact factor: 4.036

3.  Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.

Authors:  Júlio César Conceição Filho; André Lúcio Franceschini Sarria; Amanda Blanque Becceneri; Angelina Maria Fuzer; Jaqueline Raquel Batalhão; Caio Marcio Paranhos da Silva; Rose Maria Carlos; Paulo Cezar Vieira; João Batista Fernandes; Márcia Regina Cominetti
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.